• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 807

Streptococcus salivarius M18

Intended Use: For use as an ingredient in baby, infant, and toddler foods (excluding infant formula); baked goods and baking mixes; beverage and beverage bases; breakfast cereals; cheeses; chewing gum; dairy product analogs; frozen dairy desserts and mixes; gelatins, puddings, and fillings; grain products and pastas; hard candy; milk, whole and skim; milk products; nuts and nut products; processed fruits and fruit juices; soft candy; sweet sauces, toppings, and syrups at a level of 20 mg per serving, providing a minimum of 1x109 CFU/serving.
Basis: Scientific procedures
Notifier: BLIS Technologies Ltd.
Notifier Address: 81 Glasgow Street
South Dunedin, Dunedin 9012
New Zealand
GRAS Notice (releasable information): GRN 807 (in PDF) (2.4 MB)
Date of closure: Apr 18, 2019
Date of FDA’s corrected letter: Jun 6, 2019
FDA's Letter: FDA has no questions (in PDF) (62 kB)